Clarkson, Bayard

Publications

Sort by

Co-Author Network

selected publications

Effect of purified fractions from cell culture supernate of high-density pre-B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density. Electrophoresis. 2016 Academic Article GET IT
Times cited: 1
AFM study shows prominent physical changes in elasticity and pericellular layer in human acute leukemic cells due to inadequate cell-cell communication. Nanotechnology. 2016 Academic Article GET IT
Times cited: 12
The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer. Journal of cellular and molecular medicine. 2016 Academic Article GET IT
Times cited: 8
Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density. American journal of translational research. 2016 Academic Article GET IT
Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells. Nanomedicine : nanotechnology, biology, and medicine. 2016 Academic Article GET IT
Times cited: 7
Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems. American journal of cancer research. 2016 Academic Article GET IT
Commentary on Sandberg et al., "The In Vivo Chromosome Constitution of Marrow". Cancer research. 2016 Article GET IT
Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia. Blood cancer journal. 2011 Academic Article GET IT
Times cited: 31
Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities. Journal of oncology. 2011 Academic Article GET IT
Times cited: 26
Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib. Molecular cancer research : MCR. 2010 Academic Article GET IT
Times cited: 33
Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 75
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors. Bioorganic & medicinal chemistry letters. 2009 Academic Article GET IT
Times cited: 11
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS computational biology. 2009 Academic Article GET IT
Times cited: 54
A solid-phase Bcr-Abl kinase assay in 96-well hydrogel plates. Analytical biochemistry. 2007 Academic Article GET IT
Times cited: 19
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. The Journal of clinical investigation. 2007 Academic Article GET IT
Times cited: 586
Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib. Journal of medicinal chemistry. 2007 Academic Article GET IT
Times cited: 36
Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Academic Article GET IT
Times cited: 120
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. International journal of cancer. 2007 Academic Article GET IT
Times cited: 196
Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells. Proteomics. 2006 Academic Article GET IT
Times cited: 39
Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance. Proceedings of the National Academy of Sciences of the United States of America. 2006 Academic Article GET IT
Times cited: 100
Loss of p53 impedes the antileukemic response to BCR-ABL inhibition. Proceedings of the National Academy of Sciences of the United States of America. 2006 Academic Article GET IT
Times cited: 110
Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors. Nuclear medicine and biology. 2005 Academic Article GET IT
Times cited: 16
PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Blood. 2005 Academic Article GET IT
Times cited: 62
A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor. Blood. 2004 Academic Article GET IT
Times cited: 73
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate. Leukemia. 2004 Academic Article GET IT
Times cited: 29
Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. Nature genetics. 2004 Academic Article GET IT
Times cited: 58
Gleevec inhibits beta-amyloid production but not Notch cleavage. Proceedings of the National Academy of Sciences of the United States of America. 2003 Academic Article GET IT
Times cited: 178
Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors. Cancer research. 2003 Academic Article GET IT
Times cited: 73
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia. 2003 Information Resource GET IT
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell. 2003 Academic Article GET IT
Times cited: 638
Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells. Molecular cancer research : MCR. 2003 Academic Article GET IT
Times cited: 12
Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer research. 2002 Academic Article GET IT
Times cited: 154
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer research. 2002 Academic Article GET IT
Times cited: 868
Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. The Journal of biological chemistry. 2002 Academic Article GET IT
Times cited: 42
p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). The Journal of experimental medicine. 2001 Academic Article GET IT
Times cited: 100
Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science (New York, N.Y.). 2000 Academic Article GET IT
Times cited: 1561
The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells. Cellular signalling. 2000 Academic Article GET IT
Times cited: 23
Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210(BCR-ABL). Leukemia research. 2000 Academic Article GET IT
Times cited: 8
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood. 1999 Academic Article GET IT
Times cited: 137
Discordant erythropoiesis in CML. Leukemia. 1998 Article GET IT
Times cited: 1
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. The Journal of biological chemistry. 1998 Academic Article GET IT
Times cited: 116
p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell. 1997 Academic Article GET IT
Times cited: 338
c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. Leukemia. 1996 Academic Article GET IT
c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Leukemia. 1996 Academic Article GET IT
Times cited: 32
Specific genetic defects as targets for selective therapies. Commentary. Current opinion in hematology. 1994 Information Resource GET IT
Times cited: 1
Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group. British journal of haematology. 1994 Academic Article GET IT
Times cited: 23
Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Leukemia. 1994 Academic Article GET IT
Times cited: 30
A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. Leukemia. 1994 Academic Article GET IT
Times cited: 30
Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia. 1993 Information Resource GET IT
Times cited: 68
Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand. Leukemia research. 1993 Academic Article GET IT
Times cited: 9
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer. 1993 Academic Article GET IT
Times cited: 79
Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand. Cancer research. 1993 Academic Article GET IT
Times cited: 21
Integration of molecular and biological abnormalities in quest for selective treatment of chronic myelogenous leukemia (CML). Leukemia & lymphoma. 1993 Academic Article GET IT
Times cited: 5
On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. Journal of the American Statistical Association. 1993 Article GET IT
TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro. Experimental hematology. 1992 Academic Article GET IT
Times cited: 19
Consistent genetic abnormalities in human cancers as targets for selective therapies. The Mount Sinai journal of medicine, New York. 1992 Information Resource GET IT
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow. Bone marrow transplantation. 1992 Academic Article GET IT
Times cited: 32
Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. American journal of hematology. 1992 Academic Article GET IT
Times cited: 14
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia. Seminars in oncology. 1992 Academic Article GET IT
Times cited: 20
Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors. Experimental hematology. 1992 Academic Article GET IT
Times cited: 23
Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood. 1992 Academic Article GET IT
Times cited: 43
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. The New England journal of medicine. 1992 Academic Article GET IT
Times cited: 48
Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 75
The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Cancer research. 1991 Academic Article GET IT
Times cited: 24
Retinoic acid in acute promyelocytic leukemia: the promise and the paradox. Cancer cells (Cold Spring Harbor, N.Y. : 1989). 1991 Information Resource GET IT
Times cited: 21
Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Leukemia. 1991 Academic Article GET IT
Times cited: 35
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination. Blood. 1991 Academic Article GET IT
Times cited: 40
Mathematical model of granulocytopoiesis and chronic myelogenous leukemia. Cancer research. 1991 Academic Article GET IT
Times cited: 41
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood. 1991 Academic Article GET IT
Times cited: 355
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 215
Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. The American journal of medicine. 1991 Academic Article GET IT
Times cited: 41
Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype. Blood. 1991 Academic Article GET IT
Times cited: 76
Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction. Leukemia research. 1991 Academic Article GET IT
Times cited: 7
Diffuse large cell lymphoma. Prognostic factors with treatment. Leukemia. 1991 Academic Article GET IT
Times cited: 10
Treatment of Philadelphia Chromosome Positive (Ph +) Chronic Myelogenous Leukemia in Blast Crisis and Ph + Acute Leukemia with High Dose Cytosine Arabinoside (HDARAC). Leukemia & lymphoma. 1991 Academic Article GET IT
Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a. Blood. 1990 Academic Article GET IT
Times cited: 92
Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Acta haematologica. 1990 Academic Article GET IT
Times cited: 17
Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Haematology and blood transfusion. 1990 Information Resource GET IT
Times cited: 28
Pharmacological elimination of tumor cells contaminating normal human bone marrow using PTT-119. Cancer communications. 1990 Academic Article GET IT
Photoradiation methods for purging autologous bone marrow grafts. Progress in clinical and biological research. 1990 Academic Article GET IT
Times cited: 17
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide. Progress in clinical and biological research. 1990 Academic Article GET IT
Times cited: 2
Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1990 Academic Article GET IT
Times cited: 47
Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Blood. 1989 Academic Article GET IT
Times cited: 18
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. International journal of radiation oncology, biology, physics. 1989 Academic Article GET IT
Times cited: 21
t(3;22)(q27;q11): a novel translocation associated with diffuse non-Hodgkin's lymphoma. Blood. 1989 Academic Article GET IT
Times cited: 101
Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells. Blood. 1989 Academic Article GET IT
Times cited: 41
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia. Leukemia. 1989 Academic Article GET IT
Times cited: 7
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia. Leukemia. 1989 Academic Article GET IT
Times cited: 87
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. Leukemia. 1989 Academic Article GET IT
Times cited: 84
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood. 1989 Academic Article GET IT
Times cited: 187
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol. Leukemia. 1989 Academic Article GET IT
Times cited: 38
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Seminars in oncology. 1989 Academic Article GET IT
Times cited: 29
4-demethoxydaunorubicin (idarubicin) in combination with 1-beta-D-arabinofuranosylcytosine in the treatment of relapsed or refractory acute leukemia. Cancer research. 1989 Academic Article GET IT
Times cited: 21
Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 7
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies. European journal of haematology. Supplementum. 1989 Academic Article GET IT
Times cited: 5
Idarubicin in acute leukemia: results of US trials. Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 3
Immunophenotypic demonstration of two natural killer surface markers, H25 and H366, on fresh human leukemic cells. Acta haematologica. 1989 Academic Article GET IT
In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation. Cancer investigation. 1989 Academic Article GET IT
Times cited: 12
Induction of nonspecific cell-mediated cytotoxicity: a multisignal event and its cellular regulation. Haematology and blood transfusion. 1989 Academic Article GET IT
Times cited: 1
Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma. Cancer genetics and cytogenetics. 1989 Academic Article GET IT
Times cited: 20
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1989 Academic Article GET IT
Times cited: 3
Use of prognostic factors in deciding therapy for adult acute lymphoblastic leukemia: new approaches at Memorial Sloan-Kettering Cancer Center (MSKCC). Bone marrow transplantation. 1989 Academic Article GET IT
Times cited: 2
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads. Blood. 1988 Academic Article GET IT
Times cited: 35
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. The Journal of clinical investigation. 1988 Academic Article GET IT
Times cited: 215
Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia. Behring Institute Mitteilungen. 1988 Academic Article GET IT
Times cited: 2
Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood. 1988 Academic Article GET IT
Times cited: 109
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. The New England journal of medicine. 1988 Academic Article GET IT
Times cited: 801
A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1988 Academic Article GET IT
Times cited: 148
AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer. 1988 Academic Article GET IT
Times cited: 221
Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation. International journal of radiation oncology, biology, physics. 1988 Academic Article GET IT
Times cited: 11
Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Cancer research. 1988 Academic Article GET IT
Times cited: 57
Anti-tumor efficacy of interleukin-2-activated killer cells in human neuroblastoma ex vivo. Experimental cell biology. 1988 Academic Article GET IT
Times cited: 2
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells. Acta haematologica. 1988 Academic Article GET IT
Times cited: 19
Comparative regimens for the ex vivo chemopurification of B cell lymphoma-contaminated marrow. Acta haematologica. 1988 Academic Article GET IT
Times cited: 7
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing. Oncology. 1988 Academic Article GET IT
Times cited: 14
Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213. Acta haematologica. 1988 Academic Article GET IT
Times cited: 7
Characterization of cellular proteins recognizing the HIV enhancer using a microscale DNA-affinity precipitation assay. Nature. 1987 Academic Article GET IT
Times cited: 67
Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Cancer research. 1987 Academic Article GET IT
Times cited: 26
Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood. 1987 Academic Article GET IT
Times cited: 88
Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. Blood. 1987 Academic Article GET IT
Times cited: 38
Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells. Blood. 1987 Academic Article GET IT
Times cited: 63
Pseudo-Philadelphia-positive acute lymphoblastic leukemia (Ph1 + ALL). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Article GET IT
Expression of two natural killer cell antigens, H-25 and H-366, by human immature myeloid cells and by erythroid and granulocytic/monocytic colony-forming units. Blood. 1987 Academic Article GET IT
Times cited: 6
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment. The American journal of medicine. 1987 Academic Article GET IT
Times cited: 15
Semen cryopreservation and artificial insemination for Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors. Cancer research. 1987 Academic Article GET IT
Times cited: 32
Cytogenetic and histologic correlations in malignant lymphoma. Blood. 1987 Academic Article GET IT
Times cited: 134
Discrepancy between flow cytometric analyses of CALLA using two monoclonal antibodies. Experimental cell biology. 1987 Academic Article GET IT
Human bone marrow CFU-GM and BFU-E localized by light scatter cell sorting. Experimental cell biology. 1987 Academic Article GET IT
Times cited: 2
Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures. Natural immunity and cell growth regulation. 1987 Academic Article GET IT
Times cited: 9
Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experience. Haematology and blood transfusion. 1987 Academic Article GET IT
Times cited: 5
Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow. Cancer research. 1986 Academic Article GET IT
Times cited: 79
Predictive model for prognosis in advanced diffuse histiocytic lymphoma. Cancer research. 1986 Academic Article GET IT
Times cited: 65
Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years. The American journal of medicine. 1986 Academic Article GET IT
Times cited: 31
Philadelphia chromosome mosaicism in chronic granulocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Article GET IT
Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. Proceedings of the National Academy of Sciences of the United States of America. 1986 Academic Article GET IT
Inhibition of recovery by actinomycin D from bleomycin-induced potentially lethal damage in a B-lymphoma cell line. Nihon Gan Chiryo Gakkai shi. 1986 Academic Article GET IT
Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
High resolution banding of chronic myeloid leukemia chromosomes. Cancer genetics and cytogenetics. 1986 Academic Article GET IT
Times cited: 12
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1986 Academic Article GET IT
Times cited: 6
Training programs in medical oncology. Annals of internal medicine. 1986 Article GET IT
Times cited: 1
Growth and development of children born to patients after cancer therapy. Cancer investigation. 1986 Academic Article GET IT
Times cited: 14
Surface immunoglobulin light chain expression in pre-B cell leukemias. Annals of the New York Academy of Sciences. 1986 Academic Article GET IT
Times cited: 2
Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients. Cancer. 1985 Academic Article GET IT
Times cited: 28
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology. Seminars in oncology. 1985 Academic Article GET IT
Times cited: 5
Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood. 1985 Academic Article GET IT
Times cited: 72
Growth of human bone marrow in vitro. Cell biology international reports. 1985 Academic Article GET IT
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis. Cancer research. 1985 Academic Article GET IT
Times cited: 57
13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia. Cancer research. 1985 Academic Article GET IT
Times cited: 91
Chronic myelogenous leukemia: is aggressive treatment indicated?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1985 Academic Article GET IT
Times cited: 23
Regulation of human peripheral blood erythroid burst-forming unit growth by T lymphocytes and T lymphocyte subpopulations defined by OKT4 and OKT8 monoclonal antibodies. Blood. 1985 Academic Article GET IT
Times cited: 29
Suppression of the normal mouse c-myc oncogene in human lymphoma cells. Nature. 1985 Academic Article GET IT
Times cited: 9
Recent advances in the treatment of acute lymphoblastic leukemia in adults and future prospects. Transactions of the American Clinical and Climatological Association. 1985 Academic Article GET IT
Relationship of Auer rods and chromosome findings to outcome in eighty-nine adults with acute nonlymphoblastic leukemia. Leukemia research. 1985 Academic Article GET IT
Times cited: 4
Summary overview of clinical session. Haematology and blood transfusion. 1985 Academic Article GET IT
Times cited: 1
VP-16 inhibits calla antibody-induced modulation of a lymphoblastic cell line. Proceedings of the American Association for Cancer Research. 1985 Article
Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proceedings of the National Academy of Sciences of the United States of America. 1984 Academic Article GET IT
Times cited: 75
Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia. The American journal of medicine. 1984 Academic Article GET IT
Times cited: 18
Treatment of immunodeficiency with interleukin-2: initial exploration. Journal of biological response modifiers. 1984 Academic Article GET IT
Times cited: 28
NHL-3 protocol. Six-drug combination chemotherapy for non-Hodgkin's lymphoma. Cancer. 1984 Academic Article GET IT
Times cited: 13
Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables. Cancer. 1984 Academic Article GET IT
Times cited: 20
Effect of very high-dose thymidine infusions on leukemia and lymphoma patients. Cancer research. 1984 Academic Article GET IT
Times cited: 18
Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation. Cancer genetics and cytogenetics. 1984 Academic Article GET IT
Times cited: 31
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood. 1984 Academic Article GET IT
Times cited: 906
Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia. Cancer research. 1984 Academic Article GET IT
Times cited: 20
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy. Blood. 1984 Academic Article GET IT
Times cited: 31
Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells. Cell and tissue kinetics. 1983 Academic Article GET IT
Times cited: 2
Modern cancer chemotherapy. Indian journal of pediatrics. 1983 Academic Article GET IT
Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1983 Academic Article GET IT
Quantification of the peripheral blood colony forming unit-culture rise following chemotherapy. Could leukocytaphereses replace bone marrow for autologous transplantation?. Transfusion. 1983 Academic Article GET IT
Times cited: 40
Marrow cytogenetic and cell-culture analyses of the myelodysplastic syndromes: insights to pathophysiology and prognosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1983 Academic Article GET IT
A technique to quantify cytoreduction in the bone marrow induced by cytotoxic chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1983 Academic Article GET IT
Times cited: 10
Patients with secondary acute myelocytic leukemia (AML) receiving "timed" sequential chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1983 Article GET IT
Times cited: 2
Phenomenon of formation of giant fat-containing cells in human bone marrow cultures induced by human serum factor: normal and leukemic patterns. Proceedings of the National Academy of Sciences of the United States of America. 1983 Academic Article GET IT
Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients. Blood. 1983 Academic Article GET IT
Times cited: 20
Prognostic significance of receptors for the third component of complement an heavy chain phenotype in diffuse B-cell lymphomas. Blood. 1983 Academic Article GET IT
Times cited: 5
T-cell imbalances in patients with multiple myeloma: an analysis by monoclonal antibodies. Journal of clinical immunology. 1983 Academic Article GET IT
Times cited: 6
Is further intensification of treatment warranted in acute nonlymphoblastic leukemia?. Cancer treatment reports. 1983 Article GET IT
Times cited: 1
Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology. 1983 Academic Article GET IT
Times cited: 60
Autologous bone marrow transplantation using unfractionated cells without rate-controlled freezing in hydroxyethyl starch and dimethyl sulfoxide. Annals of the New York Academy of Sciences. 1983 Academic Article GET IT
Times cited: 14
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). Cancer chemotherapy and pharmacology. 1983 Academic Article GET IT
Times cited: 28
The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer. 1983 Academic Article GET IT
Times cited: 92
The treatment of acute nonlymphoblastic leukemia in adults. Advances in internal medicine. 1983 Academic Article GET IT
Times cited: 6
Vergleich der therapieeffektivität von zwei induktionsprotokollen bei akuter myeloischer leukämie (AML) mittels exakter quantifizierung der knochenmarkzellularität. Oncology Research and Treatment. 1983 Article GET IT
Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. Journal of immunology (Baltimore, Md. : 1950). 1982 Academic Article GET IT
Times cited: 124
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). Blood. 1982 Information Resource GET IT
Times cited: 72
Enrichment of hematopoietic progenitor cells (CFUC and BFUE) from human peripheral blood. Experimental hematology. 1982 Academic Article GET IT
Times cited: 8
Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA). Blood. 1982 Academic Article GET IT
Times cited: 6
Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up. Cancer. 1982 Academic Article GET IT
Times cited: 50
Analysis of T-cell differentiation antigens in acute lymphatic leukemia using monoclonal antibodies. Blood. 1982 Academic Article GET IT
Times cited: 30
Cell kinetics in acute leukemia: a critical reevaluation based on new data. Cancer. 1982 Academic Article GET IT
Times cited: 44
Effects of Hoechst 33342 on survival and growth of two tumor cell lines and on hematopoietically normal bone marrow cells. Cytometry. 1982 Academic Article GET IT
Times cited: 46
Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables. Cancer. 1982 Academic Article GET IT
Times cited: 44
Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment. Blood. 1982 Academic Article GET IT
Times cited: 117
Multidisciplinary treatment of advanced Hodgkin's disease by an alternating chemotherapeutic regimen of MOPP/ABDV and low-dose radiation therapy restricted to originally bulky disease. Cancer treatment reports. 1982 Academic Article GET IT
Times cited: 22
Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia. Blood. 1982 Academic Article GET IT
Times cited: 33
A prospective study of platelet-transfusion therapy administered to patients with acute leukemia. Transfusion. 1982 Academic Article GET IT
Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis. Comparison of bone marrow biopsy and aspiration material. Leukemia research. 1982 Academic Article GET IT
Times cited: 22
Effect of Hoechst 33342 fluorochrome on survival and growth of normal human bone marrow cells and two tumor cell lines. Cell and Tissue Kinetics. 1982 Article
Effects of cytosine arabinoside and daunorubicin on survival and cell cycle progression of Chinese hamster ovary cells. Cell and tissue kinetics. 1982 Academic Article GET IT
Times cited: 3
Leukemia cell phenotype and prognosis: an analysis of 519 adults with acute leukemia. Blood cells. 1982 Academic Article GET IT
Times cited: 11
Results of intensive treatment of chronic myelogenous leukemia. Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society. 1981 Academic Article GET IT
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol. Cancer. 1981 Academic Article GET IT
Times cited: 7
Diagnostic and prognostic significance of the CFU-c assay in acute nonlymphoblastic leukemia. Cancer research. 1981 Academic Article GET IT
Times cited: 37
Induction of giant fat cells in human bone marrow culture by human serum factor. Biomedicine / [publiee pour l'A.A.I.C.I.G.]. 1981 Academic Article GET IT
Times cited: 1
The treatment of advanced hodgkin's disease. Blut. 1981 Academic Article GET IT
Times cited: 3
Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture. Cancer research. 1981 Academic Article GET IT
Times cited: 23
Marker and kinetic studies in the non-Hodgkin's lymphomas. The American journal of medicine. 1981 Academic Article GET IT
Times cited: 25
Inaccuracy of estimations of s phase fraction by reduction in cloning efficiency with hydroxyurea or tritiated thymidine. Cell and tissue kinetics. 1981 Academic Article GET IT
Times cited: 2
The significance of splenomegaly in 101 adults with acute lymphoblastic leukemia (ALL) at presentation and during remission. Blood. 1981 Academic Article GET IT
Times cited: 1
Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literature. Cancer treatment reports. 1981 Academic Article GET IT
Times cited: 14
Cytotoxic and cytokinetic effects of 1-beta-D-arabinofuranosylcytosine, daunorubicin, and 6-thioguanine on HeLa cells in culture. Cancer research. 1981 Academic Article GET IT
Times cited: 13
Cloning of fresh lymphoma cells. Medical and pediatric oncology. 1981 Academic Article GET IT
Times cited: 3
Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture. Cancer treatment reports. 1981 Academic Article GET IT
Times cited: 2
Methods and clinical relevance of terminal deoxynucleotidyl transferase determination in leukemic cells. Haematology and blood transfusion. 1981 Academic Article GET IT
Times cited: 2
Quantitation of chemotherapy-induced cytoreduction in acute leukemia. Haematology and blood transfusion. 1981 Academic Article GET IT
Times cited: 1
Synergistic effects of deoxycytidine (dCyd) on toxicity of thymidine (dThd) plus 5-fluorouracil (FUra) in HeLa cells. Proceedings of the American Association for Cancer Research. 1981 Article
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. Cancer clinical trials. 1981 Academic Article GET IT
Times cited: 19
Characterization of B-cell leukemias: a tentative immunomorphological scheme. Blood. 1980 Academic Article GET IT
Times cited: 49
Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon. Journal of immunology (Baltimore, Md. : 1950). 1980 Academic Article GET IT
Times cited: 90
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia. Cancer research. 1980 Academic Article GET IT
Times cited: 83
Analysis of multiple cell markers in acute leukemia complicating Hodgkin's disease. Cancer. 1980 Academic Article GET IT
Times cited: 11
Concanavalin A-induced suppressor cell activity in Hodgkin's disease. Clinical immunology and immunopathology. 1980 Academic Article GET IT
A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer. 1980 Academic Article GET IT
Times cited: 61
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report. Cancer. 1980 Academic Article GET IT
Times cited: 35
Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. Cancer research. 1980 Academic Article GET IT
Times cited: 40
Subpopulations of human T lymphocytes. VI. Analysis of cell markers in acute lymphoblastic leukemia with special reference to Fc receptor expression on E-rosette-forming blasts. Cancer. 1980 Academic Article GET IT
Times cited: 7
[Pro and con: Aggressive or conventional treatment of chronic myelogenous leukemia. Arguments in favor of aggressive treatment]. Der Internist. 1980 Academic Article GET IT
B cells from a patient with chronic lymphocytic leukemia bind to sheep erythrocytes: an immunological analysis. Clinical immunology and immunopathology. 1980 Academic Article GET IT
Times cited: 15
Bleomycin for treatment of immune cytopenia. The New England journal of medicine. 1980 Article GET IT
Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line. Cancer research. 1980 Academic Article GET IT
Times cited: 12
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clinical and experimental immunology. 1980 Academic Article GET IT
Times cited: 19
Heterogeneity of cell lineages in L3 leukemias. Blood. 1980 Academic Article GET IT
Times cited: 21
Quantitative analysis of cell cycle progression of synchronous cells by flow cytometry. Experimental cell research. 1980 Academic Article GET IT
Times cited: 14
Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood. 1980 Academic Article GET IT
Times cited: 202
A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias. Journal of cancer research and clinical oncology. 1980 Academic Article GET IT
Times cited: 12
Plasma beta-thromboglobulin values in thrombocytopenic patients with acute leukemia. American journal of hematology. 1980 Academic Article GET IT
Times cited: 13
The treatment of advanced Hodgkin's disease at Memorial Hospital. Clinical bulletin. 1980 Academic Article GET IT
Times cited: 1
Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester. Biomedicine / [publiee pour l'A.A.I.C.I.G.]. 1979 Academic Article GET IT
Times cited: 10
Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol). Blood. 1979 Academic Article GET IT
Times cited: 167
Clinical significance of TdT, cell surface markers and CFU-C in 297 patients with hematopoietic neoplasias. Haematology and blood transfusion. 1979 Academic Article GET IT
Times cited: 4
Correlation of biochemical and immunological markers with conventional morphology and clinical features in 120 patients with malignant lymphomas. Advances in experimental medicine and biology. 1979 Academic Article GET IT
Times cited: 2
Difficulties in estimating the fraction of clonogenic cells in S phase using cloning efficiency in semi-solid medium in conjunction with cytotoxic hydroxyurea (HU) or 3H-thymidine (3H-TdR). Proceedings of the American Association for Cancer Research. 1979 Article
Subpopulations of human peripheral blood cells: analysis of granulocytic progenitor cells by flow cytometry and immunologic surface markers. American journal of hematology. 1979 Academic Article GET IT
Times cited: 7
Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 1978 Academic Article GET IT
Times cited: 121
The L-5 protocol: intensive treatment for patients with chronic myeloid leukemia. Bollettino dell'Istituto sieroterapico milanese. 1978 Academic Article GET IT
Times cited: 3
Prophylactic heparin therapy in acute promyelocytic leukemia. Cancer. 1978 Academic Article GET IT
Times cited: 95
Current concepts of leukemia and results of recent treatment programs. Transplantation proceedings. 1978 Information Resource GET IT
Times cited: 5
Improved biochemical assay for terminal deoxynucleotidyl transferase in human blood cells: Results in 89 adult patients with lymphoid leukemias and malignant lymphomas in leukemic phase. Leukemia Research. 1978 Article GET IT
Long term remission of acute non-lymphocytic leukemia in patients with previously treated testicular carcinoma. Proceedings of the American Association for Cancer Research. 1978 Article
Combination chemotherapy (M-2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea,(M-2 protocol). Clinical Bulletin. 1977 Article
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. The American journal of medicine. 1977 Academic Article GET IT
Times cited: 156
Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlations with clinical features and conventional morphology. The American journal of medicine. 1977 Academic Article GET IT
Times cited: 65
Alternative modes of population growth inhibition in a human lymphoid cell line growing in suspension. Experimental cell research. 1977 Academic Article GET IT
Times cited: 29
Cell marker analysis in acute monocytic leukemias. Blood. 1977 Academic Article GET IT
Times cited: 22
The G0-G1 transition of WI38 cells. I. Laser flow microfluorimetric studies. Experimental cell research. 1977 Academic Article GET IT
Times cited: 36
Prognostic factors in chronic lymphocytic leukaemia and their implications for therapy. Clinics in haematology. 1977 Information Resource GET IT
Times cited: 56
Combination chemotherapy (M 2 protocol) of Waldenstrom's macroglobulinemia with melphalan, cyclophosphamide, vincristine, and BCNU (1,3 bis(2 chlorethyl) 1 nitrosourea, (M 2 protocol). Proceedings of the American Association for Cancer Research. 1977 Article
Cyclophosphamide L2 protocol: a combination chemotherapeutic regimen for advanced non-hodgkin's lymphoma. Cancer treatment reports. 1977 Academic Article GET IT
Times cited: 15
Effect of tetrahydrouridine (THU) on metabolism of cytosine arabinoside (ARA-C) in human leukemic cells. Proceedings of the American Association for Cancer Research. 1976 Article
Physical-chemical characterization of living cells by laser-flow microfluorometry. Cancer treatment reports. 1976 Academic Article GET IT
Times cited: 11
The role of bone marrow aspiration and biopsy in detecting marrow involvement by nonhematologic malignancies. Cancer. 1976 Academic Article GET IT
Times cited: 13
Flow cytofluorometric analysis of cell cycle distributions using propidium iodide. Properties of the method and mathematical analysis of the data. The Journal of cell biology. 1976 Academic Article GET IT
Times cited: 204
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease. Cancer treatment reports. 1976 Academic Article GET IT
Times cited: 23
Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations. Computers and biomedical research, an international journal. 1976 Academic Article GET IT
Times cited: 24
Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens. Cancer. 1976 Academic Article GET IT
Times cited: 87
Cell kill kinetics with hydroxyurea. Medical and pediatric oncology. 1976 Academic Article GET IT
Times cited: 12
A scanning electron microscopy and immunological study of 84 cases of lymphocytic leukaemia and related lymphoproliferative disorders. Scandinavian journal of haematology. 1975 Academic Article GET IT
Times cited: 17
Arabinosylcytosine (ara C) and 2,2' anhydro arabinosyl 5 fluorocytosine (AAFC) in the treatment of acute leukemia. EXCERPTA MEDICA, ICS NO.354. 1975 Article
Effects of daunomycin on human leukemic cells in vivo as studied by flow microfluorimetry. Proceedings of the American Association for Cancer Research. 1975 Article
Intensive drug combination and Ommaya device for prophylactic chemotherapy in lymphoblastic leukemia. Proceedings of the American Association for Cancer Research. 1975 Article
Metabolism of cytosine arabinoside (ARA C) in vitro by normal and leukemic blood and bone marrow. Proceedings of the American Association for Cancer Research. 1975 Article
The kinetic significance of cell size, I. Variation of cell cycle parameters with size measured at mitosis. Experimental cell research. 1975 Academic Article GET IT
Times cited: 36
The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase. Experimental cell research. 1975 Academic Article GET IT
Times cited: 13
A scanning electron microscopic study of 34 cases of acute granulocytic, myelomonocytic, monoblastic and histiocytic leukemia. The American journal of medicine. 1975 Academic Article GET IT
Times cited: 32
Treatment of acute leukemia in adults. Cancer. 1975 Academic Article GET IT
Times cited: 177
Studies of cellular proliferation in human leukemia. VIII. The generation time and growth fraction in lymphosarcoma in a leukemic phase during advanced and early relapsing disease. Cancer. 1975 Academic Article GET IT
Times cited: 10
Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy. Cancer research. 1975 Academic Article GET IT
Times cited: 50
Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique. Acta cytologica. 1975 Academic Article GET IT
Times cited: 16
Control of proliferation in animal cells. COLD SPRING HARBOR LAB.. 1974 Article
Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine. Cancer research. 1974 Academic Article GET IT
Times cited: 56
Scanning electron microscopy of human leukocytes. A comparison of air dried and critical point dried cells. Israel journal of medical sciences. 1974 Academic Article GET IT
Times cited: 4
Computer analysis of tracer kinetic data from a human hematopoietic cell line during different phases of growth. Computers and biomedical research, an international journal. 1974 Academic Article GET IT
Times cited: 10
Flow microfluorometric analysis of cell killing with cytotoxic drugs. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 1974 Academic Article GET IT
Times cited: 39
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol). Cancer. 1974 Academic Article GET IT
Times cited: 78
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU. Cancer. 1974 Academic Article GET IT
Times cited: 41
The therapy of acute granulocytic leukemia in patients more than fifty years old. Annals of internal medicine. 1974 Academic Article GET IT
Identification of human B and T lymphocytes by scanning electron microscopy. The Journal of experimental medicine. 1973 Academic Article GET IT
Times cited: 246
Survival in chronic myelogenous leukemia: influence of treatment and extent of disease at diagnosis. Cancer. 1973 Academic Article GET IT
Times cited: 53
Treatment of acute myeloblastic leukemia. Bibliotheca haematologica. 1973 Academic Article GET IT
Times cited: 5
Acute myelocytic leukemia in adults. Cancer. 1972 Academic Article GET IT
Times cited: 101
Proliferative kinetics of human hematopoietic cells during different growth phases in vitro. Cancer research. 1971 Academic Article GET IT
Times cited: 30
Studies on cellular proliferation in human leukemia. VII. Cytokinetic behavior of neoplastic cells in a patient with reticulum cell sarcoma in a leukemic phase. Cancer. 1971 Academic Article GET IT
Times cited: 6
Stimulation of autochthonous lymphocytes by cells from normal and leukaemic lines. Nature: New biology. 1971 Academic Article GET IT
Times cited: 24
Studies of cellular proliferation in human leukemia. IV. Behavior of normal hemotopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days. Cancer. 1970 Academic Article GET IT
Times cited: 30
Studies of cellular proliferation in human leukemia. 3. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days. Cancer. 1970 Academic Article GET IT
Times cited: 105
Studies of cellular proliferation in human leukemia. VI. The proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia. Cancer. 1970 Academic Article GET IT
Times cited: 58
Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer. 1970 Academic Article GET IT
Times cited: 89
Toxicity of E. coli L-asparaginase in man. Cancer. 1970 Academic Article GET IT
Times cited: 239
Clinical experience with L-asparaginase. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1970 Academic Article GET IT
Times cited: 15
Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats. Cancer. 1969 Academic Article GET IT
Times cited: 12
Review of recent studies of cellular proliferation in acute leukemia. National Cancer Institute monograph. 1969 Academic Article GET IT
Times cited: 67
Treatment of adult acute leukemia with arabinosylcytosine and thioguanine. Cancer. 1969 Academic Article GET IT
Times cited: 141
Immunoglobulin synthesis by human reticulum sarcoma cells in vivo and during long-term culture in vitro. Cancer research. 1969 Academic Article GET IT
Times cited: 22
Hetero- transplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats. Cancer. 1969 Academic Article GET IT
Times cited: 36
Chromosome patterns of human leukocyte established cell lines. Cancer research. 1968 Academic Article GET IT
Times cited: 18
Formal discussion: on the cellular origins and distinctive features of cultured cell lines derived from patients with leukemias and lymphomas. Cancer research. 1967 Academic Article GET IT
Times cited: 15
Inhibition of leukemias in man by L-asparaginase. Cancer research. 1967 Academic Article GET IT
Times cited: 199
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine. Cancer research. 1967 Academic Article GET IT
Times cited: 2
Continuous culture of seven new cell lines (SK-L1 to 7) from patients with acute leukemia. Cancer. 1967 Academic Article GET IT
Times cited: 65
Electron microscopic study of human leukemic cells in tissue culture. Cancer. 1967 Academic Article GET IT
Times cited: 14
Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. The Journal of clinical investigation. 1967 Academic Article GET IT
Times cited: 123
Kinetics of proliferation of cancer cells in neoplastic effusions in man. Cancer. 1965 Academic Article GET IT
Times cited: 84
ESSENTIAL MACROGLOBULINEMIA. REPORT OF A CASE INCLUDING IMMUNOFLUORESCENT AND ELECTRON MICROSCOPIC STUDIES. Annals of internal medicine. 1965 Academic Article GET IT
Times cited: 8
PROGRESS IN LEUKEMIAS. Progress in clinical cancer. 1965 Information Resource GET IT
Times cited: 37
THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN. Clinical pharmacology and therapeutics. 1964 Academic Article GET IT
Times cited: 125
AN EXPERIMENTAL STUDY OF SIMULTANEOUS IRRADIATION AND REGIONAL CHEMOTHERAPEUTIC PERFUSION. The Journal of surgical research. 1964 Academic Article GET IT
Times cited: 2
RELATIONSHIP BETWEEN CELL TYPE, GLUCOSE CONCENTRATION, AND RESPONSE TO TREATMENT IN NEOPLASTIC EFFUSIONS. Cancer. 1964 Academic Article GET IT
Times cited: 24
BEHAVIOR OF P388 MOUSE LEUKEMIA IN THE CHICK EMBRYO AND HATCHED CHICK. Journal of the National Cancer Institute. 1964 Academic Article GET IT
Times cited: 8
REGIONAL PERFUSION OF PELVIS AND ABDOMEN BY AN INDIRECT TECHNIQUE. Acta - Unio Internationalis Contra Cancrum. 1964 Academic Article GET IT
Times cited: 1
An experimental perfusion system using the rabbit Vx-2 carcinoma. i. Studies on the effect of drug perfusions and irradiation. The Journal of surgical research. 1962 Academic Article GET IT
Times cited: 15
Experimental perfusion system utilizing the rabbit Vx-2 carcinoma. III. Correlative studies of in vitro sterilization of Vx-2 cells with results of perfusions in rabbits and in patients. Clinical pharmacology and therapeutics. 1962 Academic Article GET IT
Times cited: 3
Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver. Cancer. 1962 Academic Article GET IT
Times cited: 62
Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy. Cancer. 1961 Academic Article GET IT
Times cited: 10
Regional perfusion of the pelvis: consideration of the "leakage" problem. Surgery. 1961 Academic Article GET IT
Times cited: 17
The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine). Cancer chemotherapy reports. 1960 Academic Article GET IT
Times cited: 42

more ...

less ...

Background

education and training

M.D., Columbia University College of Physicians and Surgeons 1952
B.A., Yale University 1948

Contact

full name

Bayard Clarkson

VIVO Weill Cornell Medical College

Bayard Clarkson Professor Emeritus of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name